News

Cirius Therapeutics, Inc., developing innovative therapies for patients suffering from diseases caused by insulin resistance, ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
The poster presented at the meeting will be made available on the Glucotrack website following the conference.